Influenza vaccine, Guillain-Barré syndrome, and chasing zero

Vaccine

Volumn 30, Issue 40, 2012, Pages 5801-5803

  Poland, Gregory A ^a   Jacobsen, Steven J ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ATTRIBUTABLE RISK; DISEASE ASSOCIATION; EDITORIAL; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNIZATION; INCIDENCE; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MEDICARE; MOTONEURON; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

GUILLAIN-BARRE SYNDROME; HUMANS; INFLUENZA VACCINES; RISK ASSESSMENT; VACCINATION;

EID: 84864795489     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.093     Document Type: Editorial

References (31)

1. Jacobsen S.J., Sy L.S., Ackerson B.K., Chao C.R., Slezak J.M., Cheetham T.C., et al. An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women. Vaccine 2012, 30(May):4585-4587.
2. Poland G.A. Vaccidents and adversomics. Vaccine 2010, 28(September (40)):6549-6550.
3. Yuki N., Hartung H.P. Guillain-Barré syndrome. N Engl J Med 2012, 366(June (24)):2294-2304.
4. Hughes R.A., Rees J.H. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 1997, 176(December (Suppl. 2)):S92-S98.
5. Haber P., Sejvar J., Mikaeloff Y., DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Saf 2009, 32(4):309-323.
6. Prevots D.R., Sutter R.W. Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance. J Infect Dis 1997, 175(February (Suppl. 1)):S151-S155.
7. Schonberger L.B., Bregman D.J., Sullivan-Bolyai J.Z., Keenlyside R.A., Ziegler D.W., Retailliau H.F., et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979, 110(August (2)):105-123.
8. Marks J.S., Halpin T.J. Guillain-Barré syndrome in recipients of A/New Jersey influenza vaccine. J Am Med Assoc 1980, 243(June (24)):2490-2494.
9. Institute of medicine. Immunization safety review: influenza vaccines and neurological complications 2004, National Academies Press. K. Stratton, D.A. Alamario, T. Wizemann, M.C. McCormick (Eds.).
10. Kaplan J.E., Schonberger L.B., Hurwitz E.S., Katona P. Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system. Neurology 1983, 33(May (5)):633-637.
11. Kurland L.T., Wiederholt W.C., Kirkpatrick J.W., Potter H.G., Armstrong P. Swine influenza vaccine and Guillain-Barr' syndrome. Arch Neurol 1985, 42:1089-1090.
12. Kurland L.T., Wiederholt W.C., Beghi E., Kirkpatrick J.W., Potter H.G., Armstrong F.P. Guillain-Barr' syndrome following (A/New Jersey/76) influenza (swine flu) vaccine: epidemic or artifact?. Neurology 1986, 249-254. Springer-Verlag, Berlin/Heidelberg. K. Poeck, H.J. Freund, H. Gnshirt (Eds.).
13. Langmuir A.D., Bregman D.J., Kurland L.T., Nathanson N., Victor M. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 1984, 119(June (6)):841-879.
14. Willison H.J., Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002, 125(December (Pt. 12)):2591-2625.
15. Nachamkin I., Shadomy S.V., Moran A.P., Cox N., Fitzgerald C., Ung H., et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis 2008, 198(July (2)):226-233.
16. Schonberger L.B., Hurwitz E.S., Katona P., Holman R.C., Bregman D.J. Guillain-Barré syndrome: its epidemiology and associations with influenza vaccination. Ann Neurol 1981, 9(Suppl.):31-38.
17. Kaplan J.E., Katona P., Hurwitz E.S., Schonberger L.B. Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981 Lack of an association with influenza vaccination. J Am Med Assoc 1982, 248(August (6)):698-700.
18. Lasky T., Terracciano G.J., Magder L., Koski C.L., Ballesteros M., Nash D., et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998, 339(December (25)):1797-1802.
19. Juurlink D.N., Stukel T.A., Kwong J., Kopp A., McGeer A., Upshur R.E., et al. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 2006, 166(November (20)):2217-2221.
20. Deeks S.L., Lim G.H., Simpson M.A., Rosella L., Mackie C.O., Achonu C., et al. Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign. BMC Public Health 2011, 11:329.
21. Stowe J., Andrews N., Wise L., Miller E. Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009, 169(February (3)):382-388.
22. Lehmann H.C., Hartung H.P., Kieseier B.C., Hughes R.A. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis 2010, 10(September (9)):643-651.
23. Burwen D.R., Ball R., Bryan W.W., Izurieta H.S., La Voie L., Gibbs N.A., et al. Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001. Am J Prev Med 2010, 39(October (4)):296-304.
24. Dieleman J., Romio S., Johansen K., Weibel D., Bonhoeffer J., Sturkenboom M. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. Br Med J 2011, 343:d3908.
25. Nelson K.E. Invited commentary: influenza vaccine and Guillain-Barré syndrome - is there a risk?. Am J Epidemiol 2012, (May).
26. Greene S.K., Rett M., Weintraub E.S., Li L., Yin R., Amato A.A., et al. Risk of confirmed Guillain-Barré syndrome following receipt of monovalent inactivated Influenza A (H1N1) and seasonal influenza vaccines in the vaccine safety Datalink Project, 2009-2010. Am J Epidemiol 2012, (May).
27. Yih W.K., Lee G.M., Lieu T.A., Ball R., Kulldorff M., Rett M., et al. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the post-licensure rapid immunization safety monitoring (PRISM) system, 2009-2010. Am J Epidemiol 2012, (May).
28. Wise M.E., Viray M., Sejvar J.J., Lewis P., Baughman A.L., Connor W., et al. Guillain-Barré syndrome during the 2009-2010 H1N1 Influenza Vaccination Campaign: population-based surveillance among 45 million Americans. Am J Epidemiol 2012, 175(June (11)):1110-1119.
29. Institute of Medicine Adverse effects of vaccines: evidence and causality 2011, The National Academics Press, Washington, DC.
30. Baxter R., Lewis N., Bakshi N., Vellozzi C., Klein N.P. Recurrent Guillain-Barré syndrome following vaccination. Clin Infect Dis 2012, 54(March (6)):800-804.
31. De Wals P., Deceuninck G., Toth E., Boulianne N., Brunet D., Boucher R.M., et al. Risk of Guillain-Barre syndrome following H1N1 influenza vaccination in Quebec. JAMA 2012, 308(2):175-181.